Clinical Trial Update: Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fondaparinux to prevent blood clots in patients undergoing surgery for gynecologic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Sarcoma
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• Fondaparinux (fondaparinux)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Cervical Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-01-27